Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Understand the moments when changing budget categories makes the most sense, so you can respond to changes without derailing your plan.
12,919 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Microsoft accelerates its AI push to reclaim leadership as market re-pricing tests margins. Nadella reshapes teams an...
Markets extended their rally into a eight-week stretch, with the S&P 500 and Dow hitting fresh highs. This piece brea...
A major fund took a $61 million stake in a leading self-storage REIT just as a blockbuster $10.5 billion deal was win...
The AI revolution is just getting started, and a few names stand out as strong, long-term bets. This guide highlights...
As the United States hits its 250-year milestone, misinformation is reshaping how households spend, save, and invest....
As AI compute demand surges, a group of top tech firms are guided by female CFOs who balance growth with profitabilit...
As Baozun charts its path in 2026, investors want clarity on revenue growth, margins, and strategic bets. This articl...
New data shows wealth grows more from steady saving and patient investing than from big salaries. The piece outlines ...
When a stock seems to leap higher ahead of the broader market, investors ask: what's behind the move? This guide uses...
Microsoft’s stock has drifted lower this year even as its AI and cloud businesses show stronger momentum. This piece ...
Top five holdings make up about 37% of QQQ’s assets, with NVIDIA alone near 10%. As AI-driven spending shapes markets...